Daftarian, Helga S. DO, MPH; Lushniak, Boris D. MD, MPH; Reh, Christopher M. PhD, CIH; Lewis, Daniel M. PhD
From the Health Services Department, General Motors North America Moraine Assembly Plant, Dayton, OH (Dr Daftarian); Centers for Disease Control and Prevention, Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for Occupational Safety and Health, Cincinnati, OH (Dr Lushniak); Occupational Hygiene and Safety, The Gillette Company, Needham, Massachusetts (Dr Reh); Analytical Services Branch, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV (Dr Lewis).
Address correspondence to: Helga S. Daftarian, DO, MPH, Medical Director, Health Services Department, General Motors North America Moraine Assembly Plant, 2601 W. Stroop Road, Dayton Ohio 45439-1929; e-mail: [email protected]
This article was written by an officer or employee of the US Government as part of his/her official duties and is therefore not subject to US copyright.
